dual gip/glp-1 receptor agonist Effects of tirzepatide, a GIP and GLP-1 agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke-prone spontaneously hypertensive rats Ribupatide vs Tirzepatide: Emerging Dual

Watanabe et al., 2002)

Limitations include: Enzymatic and chemical degradation Poor membrane permeability Comparatively large molecular size When a peptide like epithalon is unmodified, bioavailability may be less than 1%

Hadley 1996) Badania porwnawcze selektywnoci receptorowej MT-II (pan-agonista MC1RMC5R, amid) vs PT-141 (preferencja MC4R, wolny kwas) vs selektywne ligandy MC1R

A network meta-analyses put tirzepatide clearly ahead on weight loss, which is the expected outcome for a dual GLP-1/GIP agonist versus a single GLP-1 agonist

Anti-inflammatory effect of glucagon-like peptide-1 receptor agonist on the neurosensory retina in an acute optic nerve injury rat model